<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://repository.usmf.md:80/handle/20.500.12710/1130">
    <title>DSpace Collection:</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/1130</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/16197" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/2939" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/2940" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/2938" />
      </rdf:Seq>
    </items>
    <dc:date>2026-05-06T00:37:45Z</dc:date>
  </channel>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/16197">
    <title>Curierul medical. August 2016, Vol. 59, No 4</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/16197</link>
    <description>Title: Curierul medical. August 2016, Vol. 59, No 4
Abstract: From its debut in 1958, the journal has striven to support the interests of&#xD;
Moldovan medicine concerning the new concepts of its development. The&#xD;
Editorial Board warmly welcomes both the readers of and the authors for the&#xD;
journal, all those who are enthusiastic in searching the new and more effective&#xD;
ways of solving numerous medical problems. We hope that those who want&#xD;
to make their contribution into the science of medicine will find our journal&#xD;
helpful and encouraging.&#xD;
The journal is accredited by the National Council for Accreditation and&#xD;
Attestation. The journal publishes official papers, scientific articles, editorials,&#xD;
clinical studies and cases, lectures, methodological guides, reviews, brief reports, and correspondence. The journal welcomes articles in English, Romanian and&#xD;
Russian. The journal editorial policy provides the prompt publication of papers&#xD;
within 12 weeks after receiving them.; De la prima apariţie în 1958, revista susţine şi dezvoltă noile idei în&#xD;
domeniul medicinii, în Republica Moldova. Colegiul de redacţie agrează cu&#xD;
multă consideraţie atât cititorii cât şi autorii articolelor, pe toţi acei care cu mult&#xD;
entuziasm caută noi şi mult mai efective metode de soluţionare a multiplelor&#xD;
probleme ale medicinii. Sperăm, că toţi acei care doresc să-şi aducă aportul&#xD;
la dezvoltarea ştiinţelor medicale, vor găsi revista noastră utilă şi atractivă.&#xD;
Revista este acreditată de către Consiliul Naţional de Acreditare și Atestare.&#xD;
Revista publică comunicări oficiale și, totodată, sunt editate diverse publicaţii,&#xD;
inclusiv independente: articole știinţifice, editoriale, cercetări și prezentări de&#xD;
cazuri clinice, prelegeri, îndrumări metodice, articole de sinteză, relatări scurte,&#xD;
corespondenţe și recenzii. Revista publică articole în limba engleză, română și&#xD;
rusă. Politica de editare a revistei prevede examinarea operativă și publicarea&#xD;
articolelor timp de 12 săptămâni după înaintare.; С первого дня своего выпуска в 1958 году журнал стремится поддерживать и развивать новые идеи в области медицины в Молдове. Редакционная коллегия всегда рада как читателям, так и авторам статей,&#xD;
всем тем, кто с энтузиазмом ищет новые, более эффективные способы&#xD;
решения многочисленных задач медицины. Мы надеемся, что все те, кто&#xD;
хотят внести свой вклад в медицинскую науку, найдут наш журнал полезным и вдохновляющим.&#xD;
Журнал аккредитован Высшей Аттестационной Комиссией Республики Молдова. В журнале печатаются официальные материалы, научные статьи, наблюдения из клинической практики, обобщающие статьи,&#xD;
краткие сообщения, методические указания, рецензии и корреспонденция. В журнале публикуются статьи на английском, румынском и русском языках. Издательская политика журнала предусматривает оперативное рассмотрение и публикацию статей в среднем в течение 12 недель после поступления.
Description: Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”</description>
    <dc:date>2016-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/2939">
    <title>Segregation of tuberculosis patients by social, demographic and economic features on the model of Chisinau city and the role of community support</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/2939</link>
    <description>Title: Segregation of tuberculosis patients by social, demographic and economic features on the model of Chisinau city and the role of community support
Authors: Lesnic, Evelina; Paladi, Carmina; Niguleanu, Adriana; Ciubotaru, Viorica; Sirbu, Petru; Curocichin, Ghenadie
Abstract: Background: One of the most important actions in tuberculosis control represents the improvement of social and economic conditions, as well as&#xD;
nutrition, hygiene, housing and working state of the population. Commission on Social determinants of Health suggests to all tuberculosis burden&#xD;
countries, especially targeting research sector, governments and academia institutions to implement health-oriented interventions, as being the most&#xD;
powerful potential efforts in tuberculosis control. The aim of the study was the segregation of tuberculosis patients according to the social, demographic&#xD;
and economic characteristics revealed at the regional level in Chisinau city for identifying target groups for improving the earlier case-detection.&#xD;
Material and methods: 185 pulmonary tuberculosis patients diagnosed in the period 01.01.2015-31.12.2015 in Chisinau city were investigated.&#xD;
Results: While segregating new cases of pulmonary tuberculosis there were identified several high risk groups for active disease: social risk groups with&#xD;
specific features – uninsured, unemployed, living in poor conditions; groups with suppressing medical conditions; epidemiologically endangered groups&#xD;
– homeless, migrants and contacts with tuberculosis patients; persons with harmful habits (alcohol abusers, injection drug users). Due to enumerated&#xD;
risk factors it was identified that one half of patients were late detected as being microscopic positive for acid-fast-bacilli that presented the highest&#xD;
epidemiological danger.&#xD;
Conclusions: Social and community support must take into account the segregation of TB patients method for improving awareness, education and&#xD;
information of high risk groups and specific groups for tuberculosis.</description>
    <dc:date>2016-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/2940">
    <title>The use of medical ozone in dentistry</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/2940</link>
    <description>Title: The use of medical ozone in dentistry
Authors: Pirgari, Andrei
Abstract: Background: Lately, due to a higher incidence rate of infections, as a result of a decreased immuno-inflammatory response capacity of the human body&#xD;
and an expanded role of viral agents in triggering inflammatory diseases, the interest for the use of medical ozone has increased significantly. The reason&#xD;
for this growth of popularity lies in the fact that medical ozone has antimicrobial, antiviral, anti-inflammatory, immunomodulatory, antioxidant and&#xD;
other properties; it is not a pharmacological product, but rather a “hormetic stress” [18], a pure ecologic physico-chemical factor with multiple biological&#xD;
effects [19].&#xD;
Conclusions: The action of medical ozone on the human body is diverse and multidirectional. The pharmacological effect of medical ozone represents&#xD;
the so-called “hormesis” phenomenon, and this effect is triggered by short chains of hydroxides – hydro-peroxides, also defined as ozone peroxides.&#xD;
Medical ozone possesses antalgic, anti-inflammatory, anti-edematous, antioxidant, myorelaxant, detoxing, immunomodulatory, antimicrobial, antiviral,&#xD;
antifungal effects, it activates the cellular metabolic processes, stimulates oxygen metabolism and improves rheological properties of blood. In dentistry,&#xD;
medical ozone is used on its own or in combination with other treatment methods. At the same time, the aspects of the use of medical ozone in clinical&#xD;
periodontology requires additional research.</description>
    <dc:date>2016-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/2938">
    <title>Evaluation of Tetracyclines and Aminoglycosides consumption</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/2938</link>
    <description>Title: Evaluation of Tetracyclines and Aminoglycosides consumption
Authors: Bernaz, Emilian P.; Vovc, Liviu
Abstract: Background: Tetracyclines and Aminoglycosides antimicrobials hold the last positions among all main antibiotic subgroups used yearly in hospitals.&#xD;
Nevertheless,without these medical remedies a qualified treatment of patients with different illnesses cannot be well organized or even would be impossible.&#xD;
Material and methods: For this study we used data of a six-year (2009-2014) period, in the Emergency Medicine Institute and their subdivisions where&#xD;
happened main consumption of antibiotics such as: Reanimation, Therapeutic intensive care, Therapeutic "stroke” intensive care, septic Surgery and&#xD;
septic Orthopedic-Traumatology departments - which show the consumption dynamics of Tetracyclines and Aminoglycosides antimicrobials use in&#xD;
grams and value indexes.&#xD;
Results: The defined daily doses (DDD) per 1000 occupied-bed days (DDD/1000) in Emergency Medicine Institute in 2009 and 2014 for Tetracyclines&#xD;
registered an increase from 8.2 to 20.8 or a share of 1.24% and 4.48% from the total annual consumption. Aminoglycosides recorded a decrease from&#xD;
83.1 to 43.7 that represents a share of 12.55% and 9.42% from the total annual consumption. The same data in Intensive care departments recorded&#xD;
for Tetracyclines an increase from 3.61 to 53.98 DDD/1000 or 0.27% and 4.48% and respectively for Aminoglycosides from 494.49 to 134.4 or 15.12%&#xD;
and 11.16%. Septic departments recorded from 3.56 to 17.63 DDD/1000 or 0.57% and 3.44% and respectively for Aminoglycosides from 142.83 to&#xD;
137.04DDD/1000 or 22.64% and 26.77%. In the mentioned period medium consumption in international hospitals of Tetracycline’s increased from 27.00&#xD;
to 70.00 DDD/1000 or by 2.59 times, and comparatively with the EMI in 2014 was higher by 3.36 times. Aminoglycosides consumption in international&#xD;
hospitals decreased from 50.00 to 40.00 DDD/1000 or by 20% and in 2014 year was similar with the data recorded in EMI. Cost of DDD/1000 in&#xD;
Emergency Medicine Institute during 2009 and 2014 years, for Tetracyclines registered 1.89 and 5.57 lei, for Aminoglycosides respectively 461.19 and&#xD;
460.83 lei. In Intensive care departments costs recorded 0.98 and 14.44 lei and 2793.61 and 2634.39 lei, and in Septic departments 0.4 and 4.75 lei and&#xD;
536.61 and 329.23 lei respectively.&#xD;
Conclusions: We found an increase in consumption of Tetracyclines DDD/1000 during the evaluated period, at the same time consumption in international&#xD;
hospitals in 2014 was in medium 70.00 DDD/1000 or 3.36 times more than 20.8 DDD/1000 recorded in EMI. Aminoglycosides in the evaluated period&#xD;
decreased in DDD/1000 consumption in EMI and international hospitals and in 2014 was around the same.</description>
    <dc:date>2016-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

